Blog

Milan Mishkovikj: The Patient at the Center – Value-Based Healthcare in Oncology

Milan Mishkovikj/LinkedIn

Dec 21, 2024, 04:55

Milan Mishkovikj: The Patient at the Center – Value-Based Healthcare in Oncology

Milan Mishkovikj, President of the National Alliance of Patient Organizations (NAPO), shared a post on LinkedIn:

“It was my enormous pleasure to be panelist at:

‘The Patient at the Center: Value-Based Healthcare in Oncology’.

Modern medicine in oncology is evolving to provide more precise, personalized, and efficient healthcare.

In this context, as the President of the National Alliance of Patient Organizations, I have emphasized the need for thorough reforms in the approach to early diagnosis, prevention (screening), and raising awareness. My reflections focus on creating a system that addresses the real needs of patients

It is essential to consider how to build a model that supports oncology patients. Without early diagnosis, this is very difficult to achieve. Although there are initiatives for numerous projects, they often remain unfinished. Therefore, reorganization is needed to place the patient at the center.

From diagnosis, through therapy, to long-term care, comprehensive and multidisciplinary programs are required to address all challenges, stated Mishkovic.

Personalized Medicine: The Power of Biomarkers.

Modern models, including biomarker testing, have the potential to revolutionize oncology care.

Biomarkers are measurable indicators such as proteins or genes that provide valuable information about a patient’s specific cancer type. Biomarker testing enables physicians to select the most appropriate treatments for a particular condition, thereby increasing efficiency and reducing side effects.

This personalized medicine approach ensures that treatments are not universal but tailored to the individual patient profile

What Does This Mean for Patients?

For patients, biomarker testing represents hope for better diagnostics, more effective therapies, and an improved quality of life during and after treatment. With a personalized approach, healthcare becomes not only more effective but also more ethical and humane

If you are a patient or wish to learn more about the opportunities offered by this technology, openly discuss with your oncologist or specialist guiding your care. They can explain how biomarker testing may apply to your diagnosis and improve your treatment plan

This integrated and innovative healthcare system is a step forward in creating a system that truly benefits patients. As Mishkovic pointed out: ‘What I want to see is the enthusiasm and dedication to creating value that will benefit all patients’.”

Milan Mishkovikj: The Patient at the Center - Value-Based Healthcare in Oncology